We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Quest to Offer Cancer Screening Products of TriPath Imaging

By HospiMedica staff writers
Posted on 27 Mar 2003
Under the terms of a recently announced collaboration agreement, Quest Diagnostics, Inc. More...
(Teterboro, NJ, USA) will be offering the 13 Series integrated solution for cervical cancer screening of TriPath Imaging, Inc. (Burlington, NC, USA) in selected locations.

The 13 Series includes the test pack (SurePath), slide processor (PrepStain), and the slide profiler (FocalPoint). Quest will also evaluate the 13 series relative to its immediate and future needs for cervical cancer screening. In addition, Quest has installed the Tele-pathology system of TriPath in two locations and is evaluating various aspects of the system's utility. TriPath develops and sells products to improve the clinical management of cancer, including detection, diagnosis, staging, and treatment. Quest is the leading provider of diagnostic laboratory testing, information, and services in the United States.

"We believe that our technologies and expanding product pipeline will create significant value for Quest Diagnostics and its customers,” said Paul R. Sohmer, M.D., president, CEO, and chairman of TriPath Imaging.





Related Links:
Quest
TriPath

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.